e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
New frontiers in the management of interstitial and orphan lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry
Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Beatriz Lara, Esther Rodriguez, Pietro Pirina, Ignacio Blanco, Marc Miravitlles
Source:
International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Session:
New frontiers in the management of interstitial and orphan lung diseases
Session type:
Oral Presentation
Number:
4492
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Esquinas Esquinas Lopez (Lleida, Spain), Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Beatriz Lara, Esther Rodriguez, Pietro Pirina, Ignacio Blanco, Marc Miravitlles. Long-term evolution of individuals with alpha1 antitrypsin deficiency from the Spanish registry. Eur Respir J 2015; 46: Suppl. 59, 4492
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Diagnosis of alpha 1 antitrypsin deficiency in primary care
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
The national alpha-1 antitrypsin deficiency registry in Poland
Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects
Year: 2015
Degree of knowledge among physicians about the diagnosis and treatment of alpha-1 antitrypsin deficiency
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
The Irish national alpha-1 antitrypsin deficiency targeted detection programme
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Screening for alpha1-antitrypsin deficiency at a university hospital
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Differences of disease phenotypes in individuals with alpha-1-antitrypsin deficiency with genotypes PiZZ and PiSZ - Analysis from the German registry
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Medical and demographic loss of population due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Pulmonary rehabilitation (PR) in patients with COPD due to alpha-1 antitrypsin deficiency (AATD): 15 years experience at the Maugeri Institute
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Investigation of sarcopenia in Japanese COPD patients
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Differences in disease severity between combination treatments in a Swedish population
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Results of a case-detection programme for α1-antitrypsin deficiency in COPD patients
Source: Eur Respir J 2005; 26: 616-622
Year: 2005
Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
Assessment of quality of life (SGRQ) in patients with alpha-1-antitrypsin deficiency– Analysis from the German registry
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Defining asthma COPD overlap syndrome (ACOS): A population based study
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016
Prevalence of chronic kidney disease (CKD) in the UK COPD population
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Productivity losses in COPD – A population-based survey.
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Eosinophilic phenotypes of overlapping respiratory diseases in an Italian general population sample
Source: International Congress 2014 – Epidemiology of asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept